Table 3.
Hazard ratios for the association between CI with all-cause and cause-specific mortality by DM or not.
Non-DM | DM | Interaction† | |||
---|---|---|---|---|---|
Normal cognition | Cognitive impairment | Normal cognition | Cognitive impairment | ||
Participants, no. | 2,836 | 587 | 900 | 176 | |
All-cause mortality | |||||
Death, no. | 346 | 108 | 156 | 57 | |
Model 1 a | 1(ref) | 1.64(1.31,2.06)* | 1(ref) | 2.70(1.99,3.67)* | 2.77(2.12,3.61)* |
Model 2 b | 1(ref) | 1.64(1.31,2.06)* | 1(ref) | 2.31(1.69,3.14)* | 2.55(1.95,3.32)* |
Model 3 c | 1(ref) | 1.42(1.12,1.81)** | 1(ref) | 2.10(1.52,2.90)* | 2.52(1.93,3.30)* |
Model 4 d | 1(ref) | 1.44(1.13,1.82)** | 1(ref) | 2.09(1.51,2.89)* | 2.46(1.87,3.22)* |
CVD mortality | |||||
Death, no. | 144 | 52 | 63 | 33 | |
Model 1 a | 1(ref) | 2.52(1.82,3.48)* | 1(ref) | 3.93(2.57,6.03)* | 3.87(2.72,5.52)* |
Model 2 b | 1(ref) | 1.79(1.28,2.49)** | 1(ref) | 3.29(2.14,5.06)* | 3.48(2.44,4.97)* |
Model 3 c | 1(ref) | 1.45(1.02,2.06)*** | 1(ref) | 3.08(1.97,4.85)* | 3.32(2.31,4.77)* |
Model 4 d | 1(ref) | 1.48(1.04,2.11)*** | 1(ref) | 3.16(2.02,5.05)* | 3.15(2.19,4.55)* |
Cancer mortality | |||||
Death, no. | 118 | 35 | 53 | 9 | |
Model 1 a | 1(ref) | 1.83(1.25,2.68)** | 1(ref) | 1.25(0.62,2.55) | 1.19(0.61,2.32) |
Model 2 b | 1(ref) | 1.67(1.13,2.47)** | 1(ref) | 1.17(0.57,2.40) | 1.16(0.59,2.26) |
Model 3 c | 1(ref) | 1.50(1.00,2.26)*** | 1(ref) | 1.03(0.50,2.16) | 1.14(0.58,2.24) |
Model 4 d | 1(ref) | 1.51(1.01,2.28)*** | 1(ref) | 1.04(0.50,2.16) | 1.15(0.59,2.26) |
CI, cognitive impairment; DM, diabetes mellitus; CVD, cardiovascular disease; HRs, hazard ratios.
An unadjusted model.
Adjusted for age and gender.
Further adjusted for residence, education, marriage, smoking status, alcohol drinking, exercise, BMI.
Further adjusted for WC, chronic diseases (hypertension, dyslipidemia, coronary disease, COPD, and tumor), TC, TG, uric acid.
*p<0.001; **p<0.01; ***p ≤ 0.05. †Cognitive function status ∗Diabetes category.